Nocturia is a prevalent highly bothersome urinary symptom that may significantly detriment the health and wellbeing of sufferers.
It is characterized by waking at night to void, each void preceded and followed by sleep, hence leads to fragmentation of sleep and day time tiredness. This may result in reduced productivity in the work place which contributes to the significant burden to the wider society that nocturia incurs. Nocturia was traditionally viewed as one of the many urinary tract symptoms that occur due to lower urinary tract dysfunction. However, recently it has been recognized that due to its multi-factorial aetio-pathogenesis, nocturia should be viewed as distinct clinical condition in its own right. Careful assessment of the nocturic patient is essential so that treatment strategies are guided by the likely causes. Much research is currently being undertaken into the underlying causes and the optimal management approaches. This review will explore the contemporary status of research on nocturia with a focus on the current and newly available pharmacotherapies.
Written by:
Osman NI, Chapple CR, Wein A. Are you the author?
Department of Urology, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK.
Reference: Acta Physiol (Oxf). 2012 Oct 3. Epub ahead of print.
doi: 10.1111/apha.12013
PubMed Abstract
PMID: 23033860
